Elena Dale

Company: Bristol Myers Squibb

Job title: Executive Director, Neuroscience

Seminars:

Roundtable Discussion: Factoring Commercial Strategy into Clinical Trial Design & Decision Making 2:30 pm

More practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas. When is the right time to start thinking about commercialization and building up the infrastructure? How might the approach and strategy need to be adjusted for launching the drug in US markets vs international markets? How…Read more

day: Conference Day Two - Track Three

Roundtable Discussion: Discussing the Promises & Challenges of Elevating Neurodegenerative Therapeutics with a Combination Approach 2:00 pm

More practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas. Are there opportunities to enhance therapies in phase I/II by combining with another treatment to improve them? What regulatory hurdles might arise when demonstrating the additional risks or benefits of a combination therapy? How can we…Read more

day: Conference Day One - Track Three

Panel Discussion: What Have we Learned from the Last 12 Months of Alzheimer’s Drug Development? 8:15 am

What have been the main obstacles to integrating first class of anti-amyloids into the treatment paradigm? What is the impact of ARIA on penetration of these new anti-amyloid therapies into market? What is the plan to better manage the burden of ARIA going forward? Shifting focus to new emerging therapies: From anti-inflammatory and anti-tau treatments…Read more

day: Conference Day One AM